Page 123 - 《中国药房》2022年8期

·药师与药学服务·

个体化合理用药监测平台在促进慢病患者合理用药中的应用 Δ

#
＊
罗忠萍 ，赵江林 ，李震林，陈 琛（克拉玛依市中心医院药学部，新疆 克拉玛依 834000）
中图分类号 R95；R969.3 文献标志码 A 文章编号 1001-0408（2022）08-1009-05
DOI 10.6039/j.issn.1001-0408.2022.08.18

摘 要 目的 为提高医疗机构合理用药水平、加强患者个体化用药监控提供参考。方法 利用医院信息系统（HIS）调取患者就诊
信息和诊疗信息，在事前审方的基础上增加慢病用药实时监测和患者就诊频次监控模块以构建个体化合理用药监控平台。以降
糖药为例，比较个体化合理用药监测平台运行前后（2018 年 1－4 月为运行前，2019、2021 年 1－4 月为运行后）克拉玛依市中心
医院（以下简称“我院”）每月开具该药≥3次的患者数，同时比较该平台运行后（2019年1－4月和2021年1－4月）的风险处方（每
天重复开具同一种药品≥3次以上的患者处方）数和不合理处方数。结果 2021年1－4月我院超量开具二甲双胍片的患者比例显
著低于2018年同期，差异有统计学意义（16.65％ vs. 27.17％，P＜0.05）。2019年1－4月，我院有35.3％的风险处方为不合格处方；
2021年同期，我院风险处方中的不合格处方数占比降至12.82％，与2019年比较差异有统计学意义（P＜0.05）。结论 我院从就诊患者
实际情况出发，利用HIS建立的个体化合理用药监测平台符合临床用药的实际需求。该平台的投入使用明显减少了多次就诊的患者
数和不合理处方数，促进了合理用药；同时，该平台也使我院处方点评制度得到了进一步强化，提高了药学服务水平。
关键词 个体化用药；合理用药；监测平台；慢病患者

Application of individualized rational drug use monitoring platform in promoting rational drug use of
patients with chronic diseases
LUO Zhongping，ZHAO Jianglin，LI Zhenlin，CHEN Chen（Dept. of Pharmacy，Karamay Central Hospital，
Xinjiang Karamay 834000，China）

ABSTRACT OBJECTIVE To provide reference for improving rational drug use in medical institutions and strengthening
individualized rational drug use monitoring. METHODS The hospital information system（HIS）was used to retrieve the patient’s
medical information and the doctor’s medical information；on the basis of pre-examination of prescriptions，the chronic disease
medication monitoring and visiting frequency monitoring modules were added to construct individualized rational drug use
monitoring platform. Taking hypoglycemic drugs as an example，the number of patients who were prescribed the drug≥3 times a
month in Karamay Central Hospital（hereinafter referred to as“our hospital”）was compared before and after the operation of the
individualized rational drug use monitoring platform（Jan. to Apr. 2018 regarded as before operation，Jan. to Apr. 2019 and 2021
regarded as after operation）. At the same time，the number of risk prescriptions（repeatedly prescribing the same drug≥3 times a
day）and unreasonable prescriptions after the operation of the individualized rational drug use monitoring platform（Jan. to Apr.
2019 and Jan. to Apr. 2021） in our hospital were compared. RESULTS The proportion of patients who were over prescribed
Diformin tablets from Jan. to Apr. in 2021 was lower than the same period in 2018 significantly（16.65％ vs. 27.17％，P＜0.05）.
From Jan. to Apr. 2019，35.3％ of the risk prescriptions in our hospital were unqualified prescriptions；in the same period of 2021，
the proportion of unqualified prescriptions in risk prescriptions in our hospital decreased to 12.82％ ，which was statistically
significant compared with 2019（P＜0.05）. CONCLUSIONS Based on the actual situation of patients，our hospital establishes the
individualized rational drug use monitoring platform by using HIS to meet the actual needs of clinical drug use. The use of the
platform has significantly reduced the number of patients visiting doctors many times and unreasonable prescriptions，and promotes
rational drug use. At the same time，the platform also further strengthens the prescription review system of our hospital and
improves the level of pharmaceutical care.
Δ 基金项目：新疆维吾尔自治区药学会科研基金资助项目（No.
KEYWORDS individualized drug use；rational drug use；
YXH201921）
＊主管药师。研究方向：医院药学。E-mail：3358839820@qq.com monitoring platform；chronic disease patients
# 通信作者：副主任药师，硕士。研究方向：医院药学。E-mail：
1725883840@qq.com

中国药房 2022年第33卷第8期 China Pharmacy 2022 Vol. 33 No. 8 ·1009 ·